Yapay Zeka Hızlı Bakış & Çıkarımlar
AI InsightThese results are consistent with previous studies and should be taken into consideration in treatment planning.
📌 3 Maddede Bu Makale
Özet
Objective: We retrospectively evaluated treatment outcomes and prognostic factors in 86 patients with soft tissue sarcoma treated with postoperative or primary radiotherapy. Materials and Methods: Patients with soft tissue sarcoma who received postoperative or primary RT were retrospectively evaluated. Parameters such as stage, location, histopathological type, tumor size, surgical features, chemotherapy status and radiotherapy dose/fractionation were evaluated in terms of prognostic value of the disease. Results: The median age of the patients was 45 years (18-80), 45 (52%) were male and 41 (48%) were female. The median dose of radiotherapy was 60 (40-70) Gy at 1.8-2 Gy/ fraction. The median follow-up period was 53 (3-246 months) months. Five-year overall survival, disease-free survival and local control were 68%, 61% and 76%, respectively. In univariate analysis, tumor size >10 cm (p=0.01), deep location (p=0.001), grade III-IV (p=0.0001), stage III (p=0.02) and (+) surgical margin (p=0.002) for OS, grade III-IV (p=0.0001), stage III (p=0. 030) and (+) surgical margin (p=0.012); for local control, tumor localization (extremity vs other) (p=0.028), grade III-IV (p=0.004), depth (p=0.035) and (+) surgical margin (p<0.0001) were found to be significant prognostic factors. In multivariate analysis, grade III-IV for overall survival and disease-free survival (p=0.004 and p=0.001, respectively), surgical margin for local control (p=0.0001) and tumor localization (p=0.06), although not statistically significant, were found to be significant prognostic factors. Conclusion: In our study; high grade, positive surgical margins and tumor location outside the extremity were found to be the most important prognostic factors. These results are consistent with previous studies and should be taken into consideration in treatment planning.
Abstract
Objective: We retrospectively evaluated treatment outcomes and prognostic factors in 86 patients with soft tissue sarcoma treated with postoperative or primary radiotherapy. Materials and Methods: Patients with soft tissue sarcoma who received postoperative or primary RT were retrospectively evaluated. Parameters such as stage, location, histopathological type, tumor size, surgical features, chemotherapy status and radiotherapy dose/fractionation were evaluated in terms of prognostic value of the disease. Results: The median age of the patients was 45 years (18-80), 45 (52%) were male and 41 (48%) were female. The median dose of radiotherapy was 60 (40-70) Gy at 1.8-2 Gy/ fraction. The median follow-up period was 53 (3-246 months) months. Five-year overall survival, disease-free survival and local control were 68%, 61% and 76%, respectively. In univariate analysis, tumor size >10 cm (p=0.01), deep location (p=0.001), grade III-IV (p=0.0001), stage III (p=0.02) and (+) surgical margin (p=0.002) for OS, grade III-IV (p=0.0001), stage III (p=0. 030) and (+) surgical margin (p=0.012); for local control, tumor localization (extremity vs other) (p=0.028), grade III-IV (p=0.004), depth (p=0.035) and (+) surgical margin (p<0.0001) were found to be significant prognostic factors. In multivariate analysis, grade III-IV for overall survival and disease-free survival (p=0.004 and p=0.001, respectively), surgical margin for local control (p=0.0001) and tumor localization (p=0.06), although not statistically significant, were found to be significant prognostic factors. Conclusion: In our study; high grade, positive surgical margins and tumor location outside the extremity were found to be the most important prognostic factors. These results are consistent with previous studies and should be taken into consideration in treatment planning.